Research

Dr. Hani Babiker
Research
May 28, 2025 • 5 Min

RASolute 302 Trial for KRAS and Other RAS Mutations Recruiting at Multiple Sites

Dr. Hani Babiker is optimistic about the new drug to treat patients with KRAS mutations, now in a phase III trial.

An affiliate of the Lustgarten Foundation, the largest private funder of pancreatic cancer research.

Research
April 7, 2025 • 5 Min

New Phase III Clinical Trial Actively Recruiting

Dr. Zev Wainberg is enthusiastic about the phase III clinical trial combining a new drug and standard chemo to make immunotherapy more effective.

Research
March 10, 2025 • 3 Min

mRNA Vaccine Shows Sustained Immune Activity in Small Patient Group

Dr. Vinod Balachandran reports notable antitumor response in about half to the patients in his mRNA vaccine clinical trial.

Survivor Stories

Pancreatic cancer patient Ellen Robbins and her husband Bob
Survivor Stories
November 2, 2022 • 3 Min

Urinary Tract Scans Lead to My Diagnosis

Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.

pancreatic cancer patient Reesa Levy
Survivor Stories
June 27, 2022 • 4 Min

Taking a Chance on a Clinical Trial

Reesa Levy traveled to find the right pancreatic cancer doctor for her, and then joined a clinical trial for a vaccine.

pancreatic cancer patient Ira Sharp
Survivor Stories
June 1, 2022 • 5 Min

The Benefit of Multiple Clinical Trials

Dr. Ira Sharp knew that his best bet for surviving pancreatic cancer was to look for clinical trials as part of his treatment.

How do I find clinical trials?

Learn more